TCTR20210902004已完成不适用
Quantitative parameters comparison of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in patients with liver malignancies
ational Cyclotron and PET Centre, Chulabhorn Hospital0 个研究点目标入组 27 人开始时间: 2021年9月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- N/A (No limit) 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •patients with diagnosed or suspected liver malignancies who underwent 68Ga-FAPI-46 PET/CT with spot liver PET/MRI and 18F-FDG PET/CT between September 2020 and June 2021
排除标准
- •Secondary malignancy
研究者
相似试验
招募中
2 期
Evaluation of 68Ga-FAPI radiotracer in lung cancerung cancer.Malignant neoplasm of bronchus and lungIRCT20220817055732N1Shahid Beheshti University of Medical Sciences20
尚未招募
2 期
A Prospective Comparison of fluorine- and gallium-labelled Prostate Specific Membrane Antigen (PSMA) radiotracers, using Positron Emission Tomography (PET-CT), in primary and suspected recurrent Prostate Cancer (PSMA-PET-PROFILE)Cancer - ProstateProstate cancerACTRN12619000460101Sydney Local Health District140
进行中（未招募）
1 期
Comparative study of a specific imaging biomarker, 68Ga-PSMA-11, and the standard imaging protocol with 18F-Fluorocholine in the detection of Recurrence in Prostate Cancer PatientsMedDRA version: 20.0 Level: PT Classification code 10036911 Term: Prostate cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10066489 Term: Progression of prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036917 Term: Prostate cancer stage I System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10036918 Term: Prostate cancer stage II System Organ Class: 10029104 - Neoplasms benign, malignant and unspProstate CancerEUCTR2016-003740-36-PTICNAS Produção Lda.46
Unknown
不适用
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast CarcinomaBreast NeoplasmsPositron Emission TomographyFibroblast Activation Protein InhibitorFluorodeoxyglucose F18NCT05339113The National Center of Oncology, Azerbaijan100
已完成
不适用
Comparison of the diagnostic value of Ga-67 scan and F-18 DG PET in sarcoidosis patientsNL-OMON34129nucleaire geneeskunde40